BioSpace News Archive

ObsEva SA, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, announced that shareholders approved all Board proposals at its 2021 Annual General Meeting held on May 28, 2021.

This newly formed committee of international specialists will advise on the scientific and clinical aspects related to the development of Onxeo’s current and future programs

An updated analysis shows further improvement of progression-free survival, disease control rate and objective response rate in the cohort of FGFR2 gene fusion-positive patients with bile duct cancer (iCCA) in FIDES-01 study

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will host a Key Opinion Leader call on June 4, 2021 from 8:00 am to 9:00 am EDT.

NH TherAguix, a clinical stage company developing innovative nanomedicines for the treatment of cancer, and the CHU Grenoble Alpes announce the publication of the results of the First-In-Human phase 1 clinical trial on the combination of AGuIX, its candidate drug, with radiotherapy on multiple brain metastases patients,by Verry Camilleet al., in Radiotherapy & Oncology medical journal.

Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022

RhoVac AB, a Swedish cancer immunotherapy company, announces , May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021.

VITALHUB CORP. is pleased to report that newly acquired subsidiary, S12 Solutions, has achieved significant market penetration since February 2021.

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that Mr. André Dupras is joining the Company as Vice President, Human Resources.

PENTAX Medical and Jiangsu Vedkang Medical Science and Technology Co., Ltd announced the establishment of a joint venture- PENTAX Medical Therapeutics Co., Ltd. to develop single-use therapeutics products in the field of flexible medical endoscopy.